Skip to main content
logo
Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
13.44
+0.46 (3.54%)
At close: Jul 27, 2026, 4:00 PM EDT
13.23
-0.21 (-1.56%)
Pre-market: Jul 28, 2026, 4:01 AM EDT

Greenwich LifeSciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-21.76-19.36-17.41-8.89-7.83-4.57
Depreciation & Amortization
000000
Stock-Based Compensation
6.86.87.252.381.740.66
Other Adjustments
-0.370.31---
Changes in Accounts Payable
1.842.072.550.04--0.53
Changes in Accrued Expenses
-0.030.20.04-0-0.120.14
Operating Cash Flow
-12.78-9.91-7.27-6.48-6.2-4.29
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
20.39124.37--3.11
Repurchase of Common Stock
-----7.54-
Net Common Stock Issued (Repurchased)
20.39124.37--7.543.11
Other Financing Activities
------0.28
Financing Cash Flow
20.54124.37--7.542.84

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
7.762.09-2.9-6.48-13.74-1.46

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-12.78-9.91-7.27-6.48-6.2-4.29
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.95-0.73-0.56-0.50-0.48-0.33
Levered Free Cash Flow
-19.95-17.08-14.83-8.86-7.94-4.95
Unlevered Free Cash Flow
-20.09-17.17-15.05-9.29-8.16-4.98
SEC Filings: 10-K · 10-Q